阿尔茨海默病风险的性别差异:内分泌与 chronological 衰老的脑影像研究
控制年龄后,围绝经期和绝经后女性较对照组女性和男性表现出AD内表型指标增加,包括代谢减低、Aβ沉积增加和AD易感区灰白质体积减少(p<0.001),且异常程度绝经后>围绝经期>对照组。APOE4阳性绝经后女性Aβ沉积较其他组加重(p<0.001)。结论提示女性临床前AD阶段较早,与围绝经期内分泌过渡重合,治疗干预最佳窗口在女性内分泌衰老早期。
要点
- 围绝经期和绝经后女性已出现AD内表型影像异常,早于临床认知下降。
- AD影像异常程度随内分泌衰老进程加重:绝经后>围绝经期>对照组。
- APOE4阳性绝经后女性Aβ沉积进一步加重。
核心结论
- 多模态脑影像提示AD内表型发展存在性别差异,女性临床前AD阶段较早,与围绝经期内分泌过渡重合。
- 女性治疗干预的最佳机会窗口可能在内分泌衰老早期。
研究设计与样本
- 所有受试者接受容积MRI、18F-FDG-PET和匹兹堡化合物B-PET扫描。
主要发现
- 控制年龄后,围绝经期和绝经后女性较对照组女性和男性表现出AD内表型指标增加,包括代谢减低、Aβ沉积增加和AD易感区灰白质体积减少(p<0.001)。
- AD生物标志物异常程度绝经后最重、围绝经期中度、对照组女性最轻(p<0.001)。
- APOE4阳性绝经后女性Aβ沉积较其他组加重(p<0.001)。
- 各组临床和神经心理学测量及APOE4分布具有可比性。
临床怎么用
- 对围绝经期女性可考虑早期评估AD影像生物标志物,以识别临床前AD风险。
- 女性AD预防性干预窗口可能前移至围绝经期内分泌过渡期。
局限性
- 绝经后组年龄大于围绝经期和对照组,虽控制年龄但组间年龄差异仍存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This observational multimodality brain imaging study investigates emergence of endophenotypes of late-onset Alzheimer disease (AD) risk during endocrine transition states in a cohort of clinically and cognitively normal women and age-matched men. METHODS: Forty-two 40- to 60-year-old cognitively normal women (15 asymptomatic perimenopausal by age [CNT], 13 perimenopausal [PERI], and 14 postmenopausal [MENO]) and 18 age- and education-matched men were examined. All patients had volumetric MRI, 18F-fluoro-2-deoxyglucose (FDG)-PET (glucose metabolism), and Pittsburgh compound B-PET scans (β-amyloid [Aβ] deposition, a hallmark of AD pathology). RESULTS: As expected, the MENO group was older than the PERI and CNT groups. Otherwise, groups were comparable on clinical and neuropsychological measures and APOE4 distribution. Compared to CNT women and to men, and controlling for age, PERI and MENO groups exhibited increased indicators of AD endophenotype, including hypometabolism, increased Aβ deposition, and reduced gray and white matter volumes in AD-vulnerable regions (p < 0.001). AD biomarker abnormalities were greatest in MENO, intermediate in PERI, and lowest in CNT women (p < 0.001). Aβ deposition was exacerbated in APOE4-positive MENO women relative to the other groups (p < 0.001). CONCLUSIONS: Multimodality brain imaging indicates sex differences in development of the AD endophenotype, suggesting that the preclinical AD phase is early in the female aging process and coincides with the endocrine transition of perimenopause. These data indicate that the optimal window of opportunity for therapeutic intervention in women is early in the endocrine aging process.
引用
- Mosconi L, Berti V, Quinn C, et al. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Neurology. 2017. PMID: 28855400. doi:10.1212/WNL.0000000000004425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。